ACM
MDNA

AIGH Capital Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

AIGH Capital Management’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,339,983
Closed -$1.27M – 55
2023
Q3 		$1.27M Hold
4,339,983
– – 0.6% 37
2023
Q2 		$2.09M Sell
4,339,983
-7,000
-0.2% -$4.33K 0.85% 30
2023
Q1 		$2.76M Hold
4,346,983
– – 1.02% 26
2022
Q4 		$1.99M Buy
4,346,983
+496,829
+13% +$303K 0.66% 33
2022
Q3 		$3.19M Buy
3,850,154
+1,577,454
+69% +$1.78M 0.99% 22
2022
Q2 		$2.65M Hold
2,272,700
– – 0.7% 22
2022
Q1 		$2.91M Buy
2,272,700
+58,400
+3% +$90.7K 0.71% 24
2021
Q4 		$3.61M Buy
2,214,300
+1,299,300
+142% +$2.69M 1.1% 22
2021
Q3 		$2.54M Hold
915,000
– – 0.54% 36
2021
Q2 		$2.77M Buy
915,000
+75,000
+9% +$277K 0.5% 38
2021
Q1 		$3.43M Buy
+840,000
New +$3.42M 0.72% 33

Other funds holding MDNA

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

AIGH Capital Management's MDNA Position: Q4 2023 in Review

AIGH Capital Management sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 4,339,983 shares — an estimated $1.27M sold.

AIGH Capital Management first reported a position in MDNA in Q1 2021 and held it in 11 quarters. The position peaked at $3.61M in Q4 2021. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

  • AIGH Capital Management reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
  • AIGH Capital Management sold 4,339,983 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $1.27M.
  • AIGH Capital Management first reported a position in Medicenna Therapeutics Corp. Common Shares in Q1 2021 and held it in 11 quarters.
  • AIGH Capital Management's Medicenna Therapeutics Corp. Common Shares position peaked at $3.61M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on AIGH Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.